Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Join Barchart Premier to get Screeners that run automatically with the results emailed to you! FREE 30 Day Trial

Watchlist | Portfolio | Dashboard

Faster, Cleaner, Better.

Nuvo Pharmaceuticals Inc (MRVFF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] by (Cboe BZX)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]

[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]

[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]

Balance Sheet for [[ item.sessionDateDisplayLong ]]

Fiscal Year End Date: 12/31

(Values in U.S. thousands)

	12-2016	12-2015	12-2014	12-2013	12-2012
Assets
Current Assets
Cash & Cash Equivalents	7,242	38,146	43,740	12,260	N/A
Marketable Securities	6,042	N/A	9,060	0	N/A
Receivables	1,802	4,336	2,720	4,060	N/A
Inventories	2,883	1,882	1,740	960	N/A
Other current assets	1,133	1,048	710	530	0
TOTAL	$19,101	$45,411	$57,970	$17,810	$N/A

Non-Current Assets
PPE Net	924	925	1,050	1,370	N/A
Other Non-Current Assets	0	0	0	1,810	0
TOTAL	$924	$925	$1,050	$3,180	$N/A

Total Assets	$20,025	$46,336	$59,020	$21,000	$N/A

Liabilities
Current Liabilities
Accounts payable and accrued liabilities	2,754	7,192	8,280	3,810	0
Other current liabilities	2	151	0	50	N/A
TOTAL	$2,755	$7,342	$8,410	$5,920	$N/A

Non-Current Liabilities
Other Non-Current Liabilities	5	34	0	0	0
TOTAL	$5	$34	$170	$3,230	$N/A

Total Liabilities	$2,760	$7,376	$8,580	$9,150	$N/A

Shareholders' Equity
Common Shares	139,905	183,960	211,630	222,510	N/A
Retained earnings	-133,261	-156,766	-174,820	-224,900	N/A
Other shareholders' equity	2	830	1,020	1,050	0
TOTAL	$17,265	$38,960	$50,430	$11,840	$N/A

Total Liabilities And Equity	$20,025	$46,336	$59,010	$20,990	$0